Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer

CPNE3 regulates tumor cell migration, invasion, VM formation and immune evasion by acting as an oncogene in NSCLC, implying that CPNE3 can serve as a potential anti-angiogenesis target for NSCLC.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-11-28
DOI
https://doi.org/10.1007/s12672-025-04004-x
Primary Topic
Signaling Pathways in Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer

Shenhua Chen, Xiaoyu Xu, Jianjie Zhu, Lin Li et al.
Discover Oncology
Signaling Pathways in Disease
article

Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer

Shenhua Chen, Xiaoyu Xu, Jianjie Zhu, Lin Li, Yuanyuan Zeng, Jianan Huang, Liang Tian, Wenwen Du, Pei Pang
article en

Abstract

CPNE3 regulates tumor cell migration, invasion, VM formation and immune evasion by acting as an oncogene in NSCLC, implying that CPNE3 can serve as a potential anti-angiogenesis target for NSCLC.

Discover OncologyVol. 16(1)
Soochow University (CN), Suzhou Research Institute (CN), First Affiliated Hospital of Soochow University (CN)
Openalex Percentile: Top 66%
Signaling Pathways in Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.